Advertisement PBR Staff Writer, Author at Pharmaceutical Business review - Page 3538 of 4440
Pharmaceutical Business review is using cookies

ContinueLearn More
Close
 

All articles by  

Merck Serono files for EU marketing approval for sapropterin

Data from two international, double-blind, randomized, placebo-controlled Phase III clinical trials in patients with hyperphenylalaninemia due to phenylketonuria show that treatment with sapropterin reduces blood phenylalanine levels and